Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
ConditionColorectal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorADVANCED MARKER DISCOVERY S.L.
About this trial
The objective of this observational study is to evaluate the false positive rate of the blood test based on molecular biomarkers and risk factors. A total of 250 patients diagnosed with various cancers and gastrointestinal diseases will be enrolled. The main question to be answered is
Does the blood test have a low false positive rate in the main study population?
Participants will donate a blood sample as part of their regular medical care for cancer diagnosis and give the consent to know their clinical risk factors.
Eligibility criteria
Qualifiers
Patients older than 18 years of age at the time of blood sample collection.
Subjects must be able to understand the information provided on the participant information sheet, must consent to participate in the study, and must sign the informed consent form.
Patients diagnosed with only one type of cancer (no colorectal cacner) or gastrointestinal disease.
Disqualifiers
Patients who have received previous chemotherapy or radiotherapy.
In case of diagnosis of a tumor: patients who have undergone total or partial surgical resection of the tumor.
Patients with a personal history of advanced or non-advanced colorectal adenoma, serrated lesions, colorectal cancer, familial adenomatous polyposis or Lynch syndrome.
Patients without appropriate staging or diagnosis.
Trial design
Treatments tested in this trial
- blood sampling
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov